Introduction
South Africa has one of the highest tuberculosis burdens in the world, an epidemic driven largely by high human immunodeficiency virus (HIV) infection rates in the same population. 1 The problem is aggravated by low treatment success rates in patients with active tuberculosis. 1 The main categories of unsuccessful treatment are death during tuberculosis treatment, treatment interruption for two consecutive months or more, and treatment failure. 1 Patients have to take a second course of tuberculosis treatment, classified as "retreatment tuberculosis" for the latter two categories. Retreatment tuberculosis is any tuberculosis treatment occurring in a patient who has received previous antituberculosis treatment, and may be due to either reactivation following suboptimally treated tuberculosis, as explained, or exogenous re-infection. Common risk factors for treatment interruption, failure and/or retreatment tuberculosis in low-HIV prevalence settings include belonging to the male sex, being of an older age, having a low socio-economic status, initial drug resistance, alcohol abuse and tobacco smoking. [2] [3] [4] [5] [6] [7] HIV infection is an additional important risk factor for tuberculosis recurrence, in particular in patients not taking antiretroviral treatment (ART) in areas of high HIV prevalence. 8 With regard to tobacco use, smokers are more likely to have poorer intermediate clinical end-points (delayed sputum conversion and treatment interruption), 2, 9 and higher failure and recurrence rates. 3, 4, 6 The pathophysiological mechanisms are complex that underlie the increased risk and severity of tuberculosis in tobacco smokers. Tobacco smoke causes alterations in cellular and humoral immunity, and impairs lung defence mechanisms through suppression of the protective functions of the airway epithelium, all of which may explain higher recurrence rates in smokers. 10 To our knowledge, an association between smoking and retreatment tuberculosis has not been studied in a high-HIV prevalence setting. We aimed to ascertain whether or not current tobacco smokers were more likely to present with retreatment tuberculosis than non-smokers with regard to patients with high tuberculosis-HIV co-infection rates, adjusted for other important confounders.
Method
This was a cross-sectional analysis of baseline data, collected for a smoking cessation study. The study took place at six large tuberculosis clinics in Tshwane, South Africa's capital city, from September 2011 to April 2013. These clinics provide tuberculosis-and HIV-related care, and use case definitions, disease classification and treatment outcomes based on World Health Organization (WHO) guidelines. 1 Adult patients seeking tuberculosis treatment at these clinics were approached to participate in the study. Patients who were on treatment for over one month, and those who were very ill and unable to understand the language, were excluded from the study. The study was approved by the ethics committee of the University of Pretoria (Protocol 116/2011).
Information on socio-economic and demographic factors, and alcohol and tobacco use was collected through structured intervieweradministered questionnaires. Questions on tobacco use were adapted from the Global Adult Tobacco Survey questionnaire. 11 Current smoking was defined as having smoked tobacco in the past month, while ever having smoked tobacco was defined as currently smoking, or having smoked in the past. Tuberculosis-and HIV-related information was extracted from standardised individual patient tuberculosis records. Information included whether or not this was a first episode of tuberculosis or retreatment, the type of tuberculosis, the patient's HIV There is evidence from international studies that tobacco smoking increases the risk of tuberculosis recurrence through its effects on the immunological and barrier functions of the airways. In this cross-sectional study, the association between current tobacco smoking and retreatment tuberculosis was studied in a population of 1 926 South African tuberculosis patients with high human immunodeficiency virus (HIV) co-infection rates. Retreatment tuberculosis was more common in male and among HIV-positive participants currently on antiretroviral treatment, or with unknown antiretroviral treatment status. However, we did not find an association between smoking and retreatment tuberculosis. A longitudinal study is needed to confirm these findings.
status and whether or not the patient was taking ART. Information on CD4 count was not collected since this information is often missing from tuberculosis records and/or not updated in our setting. 12 According to the definitions of the WHO, a "new" tuberculosis patient is one who has never received treatment for tuberculosis, or who has taken antituberculosis drugs for less than one month.
A retreatment patient is one who was previously treated for tuberculosis, and who is started on a retreatment regimen:
• After previous treatment has failed.
• After having previously defaulted.
• After previously being declared cured, or having completed treatment, and who is diagnosed again with bacteriologically positive tuberculosis. cleaning and analysis. 13 Analysis consisted of descriptive statistics, followed by an exploratory analysis of variables associated with smoking, since these could confound the relationship between smoking and retreatment tuberculosis.
In the next step, we performed univariate and multivariate logistic regression for predictors of retreatment tuberculosis. Co-variates known to be associated with retreatment tuberculosis from a literature review, and/or those identified during univariate analysis at the 25% level, were included in the initial multivariate mode, as well as interaction variables. Co-variates were then removed one by one using backward elimination with a liberal retention criterion (p-value < 0.2), as recommended for models designed to evaluate a predictor of primary interest.
14 Standard errors were adjusted for clustering by facility. Current smoking was the primary predictor of interest. However, an alternative model, with ever smoked as the main predictor, was also run.
Results
The baseline characteristics of the 1 926 interviewed patients (485 exclusions) are presented in Table I , according to smoking status. Roughly one in five respondents was a current smoker (420/1 924, 21.8%) and 13% of respondents had previously had tuberculosis (245/1 879). The retreatment status was missing for 47 patients. The median daily number of cigarettes smoked was 8 for daily smokers (interquartile range 5-12.5, n = 352). Only 1.8% (35/1 918) of respondents were past smokers.
(The results for the number of cigarettes and past smoking status are not presented in Table I ). Following univariate analysis of potential confounders of the relationship between smoking and retreatment tuberculosis, several variables were significantly associated with current smoking, including being male, not receiving ART while HIV-positive, having an alcohol problem, living in a household with a low monthly income, not being well educated, going hungry in the past month and carrying out occasional work (Table I) .
Factors associated with retreatment tuberculosis are presented in Table  II . The small group of 35 past smokers were included in the group of non-smokers for the purpose of this analysis. After adjustment for other 15-3 .27, respectively). However, being HIV-positive, but not yet receiving ART, was not significantly associated with retreatment tuberculosis. Being aged 60 or older and with a higher household income was marginally associated with a lower retreatment rate (p-value < 0.10) (Table II) . Results were very similar in the model with ever versus never smoked as the main predictor.
Discussion
Somewhat in contrast with the findings of studies that indicated higher relapse, treatment interruption and failure rates among smokers, 2-4,6 we did not find that smoking was independently associated with tuberculosis retreatment in this cross-sectional analysis. However, some of the identified predictors of increased risk of retreatment (being of the male sex, and being HIV positive and on ART) were similar to those of other studies. 5, 8 Considering that smokers were found to be significantly more likely to be HIVpositive but not on ART than non-smokers, survival bias would have been introduced if patients who smoked died more often after a first episode of tuberculosis than non-smokers. Another explanation for the lack of association between smoking and tuberculosis retreatment is that the majority of our respondents were light smokers (1-10 cigarettes per day). Therefore, the effect of smoking may have been minimal in the context of the overwhelming influence of HIV on tuberculosis recurrence. Misclassification of retreatment status may have occurred. We did not validate whether or not patients with a self-reported first episode of tuberculosis had been registered with tuberculosis previously, at the same or another facility. Nevertheless, our retreatment rates were similar to those of national statistics based on routinely collected data, 1 but were much lower than the 28% retreatment rate in a recent study undertaken in Cape Town 8 on a population with generally higher smoking, but lower HIV-infection rates. We may also have missed some retreatment cases if retreatment patients who had multidrug-resistant tuberculosis (MDR-TB) were referred directly from a hospital to 
Conflict of interest
The authors declare no competing interests.
